0001209191-24-000766.txt : 20240104
0001209191-24-000766.hdr.sgml : 20240104
20240104161528
ACCESSION NUMBER: 0001209191-24-000766
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Jullian G
CENTRAL INDEX KEY: 0001895356
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40522
FILM NUMBER: 24512074
MAIL ADDRESS:
STREET 1: MONTE ROSA THERAPEUTICS, INC.
STREET 2: 645 SUMMER STREET, SUITE 102
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER NAME:
FORMER CONFORMED NAME: Jones Julian G
DATE OF NAME CHANGE: 20211123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monte Rosa Therapeutics, Inc.
CENTRAL INDEX KEY: 0001826457
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 HARRISON AVENUE
STREET 2: SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02118
BUSINESS PHONE: 617-949-2643
MAIL ADDRESS:
STREET 1: 321 HARRISON AVENUE
STREET 2: SUITE 900
CITY: BOSTON
STATE: MA
ZIP: 02118
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-02
0
0001826457
Monte Rosa Therapeutics, Inc.
GLUE
0001895356
Jones Jullian G
MONTE ROSA THERAPEUTICS, INC.
321 HARRISON AVENUE, SUITE 900
BOSTON
MA
02118
0
1
0
0
Chief Business Officer
0
Stock Option (Right to Buy)
5.71
2024-01-02
4
A
0
79000
0.00
A
2034-01-01
Common Stock
79000
79000
D
25% of this option shall vest and become exercisable on January 1, 2025, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Markus Warmuth, Attorney-in-Fact
2024-01-04